Validating bladder cancer xenograft bioluminescence with magnetic resonance imaging: The significance of hypoxia and necrosis

BJU International

Volumn 106, Issue 11, 2010, Pages 1799-1804

  Black, Peter C ^a   Shetty, Anil ^a   Brown, Gordon A ^a   Esparza Coss, Emilio ^a   Metwalli, Adam R ^a   Agarwal, Piyush K ^a   McConkey, David J ^a   Hazle, John D ^a   Dinney, Colin P N ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

animal model; bioluminescence imaging; bladder cancer; hypoxia; MRI

Indexed keywords

EOSIN; HEMATOXYLIN; LUCIFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; BLADDER CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; HYPOXIA; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MOUSE; NECROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TUMOR VOLUME; TUMOR XENOGRAFT; VALIDATION PROCESS;

ANIMALS; ANOXIA; CELL LINE, TUMOR; DIAGNOSTIC IMAGING; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; LUMINESCENCE; MAGNETIC RESONANCE IMAGING; MICE; MICE, NUDE; NECROSIS; NEOPLASM TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS; TUMOR BURDEN; URINARY BLADDER NEOPLASMS;

EID: 78649281064     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09424.x     Document Type: Article

References (17)

1. Klerk CP, Overmeer RM, Niers TM, et al. Validity of bioluminescence measurements for noninvasive in vivo imaging of tumor load in small animals. Biotechniques 2007; 43 (Suppl): 7 - 13
2. Edinger M, Cao YA, Hornig YS, et al. Advancing animal models of neoplasia through in vivo bioluminescence imaging. Eur J Cancer 2002; 38: 2128 - 36
3. Lyons SK,. Advances in imaging mouse tumour models in vivo. J Pathol 2005; 205: 194 - 205
4. Dinney CP, Fishbeck R, Singh RK, et al. Isolation and characterization of metastatic variants from human transitional cell carcinoma passaged by orthotopic implantation in athymic nude mice. J Urol 1995; 154: 1532 - 8
5. Arumugam T, Ramachandran V, Logsdon CD,. Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models. J Natl Cancer Inst 2006; 98: 1806 - 18
6. Kostourou V, Troy H, Murray JF, et al. Overexpression of dimethylarginine dimethylaminohydrolase enhances tumor hypoxia: an insight into the relationship of hypoxia and angiogenesis in vivo. Neoplasia 2004; 6: 401 - 11
7. Inoue K, Kamada M, Slaton JW, et al. The prognostic value of angiogenesis and metastasis-related genes for progression of transitional cell carcinoma of the renal pelvis and ureter. Clin Cancer Res 2002; 8: 1863 - 70
8. Rehemtulla A, Stegman LD, Cardozo SJ, et al. Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia 2000; 2: 491 - 5
9. Sarraf-Yazdi S, Mi J, Dewhirst MW, Clary BM,. Use of in vivo bioluminescence imaging to predict hepatic tumor burden in mice. J Surg Res 2004; 120: 249 - 55
10. Smakman N, Martens A, Kranenburg O, Borel Rinkes IH,. Validation of bioluminescence imaging of colorectal liver metastases in the mouse. J Surg Res 2004; 122: 225 - 30
11. Szentirmai O, Baker CH, Lin N, et al. Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect. Neurosurgery 2006; 58: 365 - 72
12. Peter C, Kielstein JT, Clarke-Katzenberg R, et al. A novel bioluminescent tumor model of human renal cancer cell lines: an in vitro and in vivo characterization. J Urol 2007; 177: 2342 - 6
13. Inoue Y, Izawa K, Tojo A, et al. Monitoring of disease progression by bioluminescence imaging and magnetic resonance imaging in an animal model of hematologic malignancy. Exp Hematol 2007; 35: 407 - 15
14. Hadaschik BA, Black PC, Sea JC, et al. A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imaging. BJU Int 2007; 100: 1377 - 84
15. El Hilali N, Rubio N, Martinez-Villacampa M, Blanco J,. Combined noninvasive imaging and luminometric quantification of luciferase-labeled human prostate tumors and metastases. Lab Invest 2002; 82: 1563 - 71
16. Paroo Z, Bollinger RA, Braasch DA, et al. Validating bioluminescence imaging as a high-throughput, quantitative modality for assessing tumor burden. Mol Imaging 2004; 3: 117 - 24
17. Dickson PV, Hamner B, Ng CY, et al. In vivo bioluminescence imaging for early detection and monitoring of disease progression in a murine model of neuroblastoma. J Pediatr Surg 2007; 42: 1172 - 9